Literature DB >> 16908640

Effects of beta-glucan extracted from Saccharomyces cerevisiae on growth performance, and immunological and somatotropic responses of pigs challenged with Escherichia coli lipopolysaccharide.

J Li1, D F Li, J J Xing, Z B Cheng, C H Lai.   

Abstract

Three experiments were conducted to investigate the effects of beta-glucan supplementation on pig performance and immune function. In Exp. 1, 100 weaned pigs (8.65 +/- 0.42 kg of BW and 28 +/- 2 d of age) were used in a 35-d experiment to determine the effects of graded levels of beta-glucan. Pigs were randomly allotted to 1 of 5 treatments containing beta-glucan supplemented at 0, 25, 50, 100, or 200 ppm. Each treatment was replicated using 5 pens containing 4 pigs per pen. The ADG of pigs between d 14 to 28 and d 0 to 28 responded to dietary beta-glucan in a quadratic fashion (P < 0.05), whereas beta-glucan had no effect on ADFI and G:F in any period. In Exp. 2, 80 crossbred pigs (8.23 +/- 0.56 kg of BW and 28 +/- 2 d of age) were used in a 35-d experiment. Pigs were allotted to 1 of 2 dietary treatments (0 or 50 ppm of beta-glucan in the diet) using 10 pens with 4 pigs per pen. Pigs treated with beta-glucan had greater ADG in the 14- to 28-d (P = 0.05) and 0-to 28-d (P = 0.035) periods. The ADFI of pigs receiving beta-glucan was increased (P < 0.05) in the periods from 0 to 14, 0 to 28, and 28 to 35 d. The lymphocyte proliferation index in response to phytohemagglutinin (P = 0.051) and concanavalin A (P = 0.052) tended to decrease on d 14 in pigs supplemented with beta-glucan compared with pigs without supplementation. In Exp. 3, 24 barrows (8.89 +/- 0.20 kg of BW and 28 d of age) were used to investigate the immunological and somatotropic responses of pigs challenged with lipopolysaccharide (LPS). Experimental treatments were arranged in a 2 x 2 factorial, with the main effects of LPS challenge (saline vs. LPS) and dietary addition of beta-glucan (0 vs. 50 ppm). Pigs were raised individually in metabolic cages. Pigs were fed 0 or 50 ppm of beta-glucan for 28 d and then challenged with LPS (25 microg/kg of BW) or saline. After LPS injection, blood was obtained at 0, 1.5, 3, 4.5, 6, and 7.5 h to determine cytokine production and the somatotropic response. Dietary beta-glucan increased plasma interleukin-6 at 1.5, 3, and 4.5 h and tumor necrosis factor-alpha at 3 and 4.5 h and increased plasma interleukin-10 from 3 to 7.5 h after LPS challenge. The beta-glucan treatments had no effect on growth hormone. In conclusion, beta-glucan can selectively influence performance and partially offer benefits on somatotropic axis and immune function in weaned piglets challenged with LPS.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16908640     DOI: 10.2527/jas.2004-541

Source DB:  PubMed          Journal:  J Anim Sci        ISSN: 0021-8812            Impact factor:   3.159


  23 in total

1.  Effect of anti-inflammatory compounds or antibiotic administration on receiving performance and physiological responses of transported heifers.

Authors:  Xin Wu; Na Cao; Zhenming Zhou; Paul A Beck; Hao Wu; Qingxiang Meng
Journal:  J Anim Sci       Date:  2020-02-01       Impact factor: 3.159

2.  β-Glucans inhibit intracellular growth of Mycobacterium bovis BCG but not virulent Mycobacterium tuberculosis in human macrophages.

Authors:  Bret E Betz; Abul K Azad; Jessica D Morris; Murugesan V S Rajaram; Larry S Schlesinger
Journal:  Microb Pathog       Date:  2011-07-05       Impact factor: 3.738

3.  β(1-3)(1-6)-D-glucans modulate immune status in pigs: potential importance for efficiency of commercial farming.

Authors:  Vaclav Vetvicka; Carlos Oliveira
Journal:  Ann Transl Med       Date:  2014-02

4.  Immunomodulatory effects of whole yeast cells and capsicum in weanling pigs challenged with pathogenic Escherichia coli1.

Authors:  Samantha J Wojnicki; Antrison Morris; Brooke Nicole Smith; Carol W Maddox; Ryan Neil Dilger
Journal:  J Anim Sci       Date:  2019-04-03       Impact factor: 3.159

5.  Dectin1 activation of β-(1-3)/(1-6)-D-glucan produces an anti-mastitis effect in rats.

Authors:  Wei Zhu; Beibei Gu; Jinfeng Miao; Jingye Lu; Sixiang Zou
Journal:  Inflamm Res       Date:  2011-06-21       Impact factor: 4.575

6.  Effects of dietary yeast Saccaromyces cerevisiae on the antioxidant system in the liver of juvenile sea bass Dicentrarchus labrax.

Authors:  Maria Pia Santacroce; Elisabetta Merra; Gerardo Centoducati; Valentina Zacchino; Elisabetta Casalino
Journal:  Fish Physiol Biochem       Date:  2012-04-08       Impact factor: 2.794

7.  Brucella β 1,2 cyclic glucan is an activator of human and mouse dendritic cells.

Authors:  Anna Martirosyan; Camino Pérez-Gutierrez; Romain Banchereau; Hélène Dutartre; Patrick Lecine; Melissa Dullaers; Marielle Mello; Suzana Pinto Salcedo; Alexandre Muller; Lee Leserman; Yves Levy; Gerard Zurawski; Sandy Zurawski; Edgardo Moreno; Ignacio Moriyón; Eynav Klechevsky; Jacques Banchereau; Sangkon Oh; Jean-Pierre Gorvel
Journal:  PLoS Pathog       Date:  2012-11-15       Impact factor: 6.823

8.  Influence of Feeding Enzymatically Hydrolyzed Yeast Cell Wall on Growth Performance and Digestive Function of Feedlot Cattle during Periods of Elevated Ambient Temperature.

Authors:  J Salinas-Chavira; C Arzola; V González-Vizcarra; O M Manríquez-Núñez; M F Montaño-Gómez; J D Navarrete-Reyes; C Raymundo; R A Zinn
Journal:  Asian-Australas J Anim Sci       Date:  2015-09       Impact factor: 2.509

9.  A novel beta-glucan produced by Paenibacillus polymyxa JB115 induces nitric oxide production in RAW264.7 macrophages.

Authors:  Zhi Qiang Chang; Joong Su Lee; Mi Hyun Hwang; Joo Heon Hong; Hee Kyoung Jung; Sam Pin Lee; Seung Chun Park
Journal:  J Vet Sci       Date:  2009-06       Impact factor: 1.672

10.  Modulation of intestinal inflammation by yeasts and cell wall extracts: strain dependence and unexpected anti-inflammatory role of glucan fractions.

Authors:  Samir Jawhara; Khalid Habib; François Maggiotto; Georges Pignede; Pascal Vandekerckove; Emmanuel Maes; Laurent Dubuquoy; Thierry Fontaine; Yann Guerardel; Daniel Poulain
Journal:  PLoS One       Date:  2012-07-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.